Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 3, 2008, Pages 258-263

  Lu, Sen ^a   Yu, Yue ^a   Gao, Yun ^a   Li, Guo Qiang ^a   Wang, Xue Hao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; CTLA4Ig; Liver transplantation; Transplantation tolerance

Indexed keywords

ABATACEPT; AGAROSE; COMPLEMENTARY DNA; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LACTIC ACID; MESSENGER RNA; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; NONVIRAL GENE THERAPY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINATION; VIRUS STRAIN;

ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GRAFT REJECTION; IMMUNE TOLERANCE; IMMUNOCONJUGATES; LIVER TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46049096551     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wu J, Zheng SS. Liver transplantation in China: problems and their solutions. Hepatobiliary Pancreat Dis Int 2004;3: 170-174.
2. Yang YJ, Li LX, He Q, Fan H, Jin ZK, Lang R, et al. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. Hepatobiliary Pancreat Dis Int 2007;6:376-378.
3. Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobertm E, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 2005;5:443-453.
4. Chandraker A, Huurman V, Hallett K, Yuan X, Tector AJ, Park CH, et al. CTLA-4 is important in maintaining longterm survival of cardiac allografts. Transplantation 2005; 79:897-903.
5. Snanoudj R, de Préneuf H, Créput C, Arzouk N, Deroure B, Beaudreuil S, et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006;19:693-704.
6. Hill M, Zagani R, Voisine C, Usal C, Anegon I. Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats. Transplantation 2007;84:1060-1063.
7. Wang GM, Ma JB, Jin YZ, Feng YG, Hao J, Gao X, et al. Long-term survival of cardiac allografts induced by cyclophosphamide combined with CTLA41g-gene transfer mediated by adenoviral vector. Transplant Proc 2006;38: 3043-3045.
8. Tian PX, Li ZL, Zhang YS, Xue WJ, Wu J. Prolongation of renal allograft survival in rats by replication-defective recombinant adenovirus-mediated coexpression of CD40L and CTLA4Ig. Transplant Proc 2006;38:1634-1637.
9. Wang GM, Yang Y, Jin YZ, Li AL, Hao J, Gao X, et al. Blockade of both CD28/B7 and OX40/OX40L costimulatory signal pathways prolongs the survival of islet xenografts. Transplant Proc 2005;37:4449-4451.
10. Schmitz V, Neumann UP, Fischer U, Langrehr J, Neuhaus P. Induction of long-term graft acceptance by a combination treatment of donor splenocytes and CTLA4Ig in a high responder rat liver transplantation model. Transpl Int 2005;18:1187-1196.
11. Lane P, Gerhard W, Hubele S, Lanzavecchia A, McConnell F. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. Immunology 1993;80:56-61.
12. Lu S, Wang XH, Li GQ, Gao Y, Yu Y. Construction of an adeno-associated virus vector expressing CTLA-4Ig and its expression in the transplanted liver allografts. Zhonghua Gan Zang Bing Za Zhi 2005;13:183-186.
13. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93:64-69.
14. Peng Y, Gong JP, Yan LN, Li SB, Li XH. Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int 2004;3:33-37.
15. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998;72:2224-2232.
16. Chen D, Sung R, Bromberg JS. Gene therapy in transplantation. Transpl Immunol 2002;9:301-314.
17. Chen Z, Lu L, Li J, Xiao X, Fung JJ, Qian S. Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery 2003;23:489-493.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. L Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
19. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993;11:29-48.
20. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992;53:151-156.
21. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992;53:449-456.
22. Wu CJ, Lovett M, Wong-Lee J, Moeller F, Kitamura M, Goralski TJ, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992;54:326-332.
23. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 1996; 93:13967-13972.
24. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant nd anti-apoptotic genes. Nat Med 1998;4:1392-1396.
25. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term icceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-438.
26. Bartlett AS, McCall JL, Ameratunga R, Howden B, Yeong ML, Benjamin CD, et al. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat. Liver Transpl 2002;8:458-468.